Skip to main content
Premium Trial:

Request an Annual Quote

Sentigen Shareholders Approve Invitrogen Acquisition

NEW YORK (GenomeWeb News) - Sentigen Holding today said that its stockholders have approved its planned merger with Invitrogen.
 
Sentigen said it expects the deal to close “within the next several weeks.”
 
As GenomeWeb News reported in August, Invitrogen said it planned to acquire Sentigen, which includes its subsidiaries Sentigen Biosciences and Cell & Molecular Technologies for
For around $25.9 million.

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.